EUVIMEDObjevte EUVIMED
Übersichtsarbeit

A Comprehensive Review of Melatonin as Multi-Pathway Neuroprotectant Against Methamphetamine-Induced Programmed Cell Death: Discovery of the Circadian-Ferroptosis Axis

Noel Pabalan, Sarawut Lapmanee, Phuntila Tharabenjasin, Panan Suntornsaratoon, Orapan Thosingha, Anorut Jenwitheesuk

Neurosignals · 2026-04-17 · 33 (1) · 1-18

DOI: 10.33594/000000861 ↗

At a glance

Übersichtsarbeit in Neurosignals, published online on 2026-04-17. Written by Noel Pabalan and 5 co-authors. Institution: Chulabhorn International College of Medicine, Thammasat University (Rangsit Campus), Cooperative Learning Center, Piyachart 2, 99 Moo 18 Klong Luang,…. Major MEDLINE topics: Melatonin, Methamphetamine, Neuroprotective Agents, Apoptosis. Funded by: Chulabhorn Royal Academy (Fundamental Fund by National Science and Research Innovation Fund, NSRF).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Introduction

Methamphetamine (METH) abuse affects 34 million individuals globally, causing severe neurotoxicity through multiple programmed cell death (PCD) pathways. No approved pharmacotherapies exist. We comprehensively examined melatonin's neuroprotective mechanisms against METH-induced apoptosis, pyroptosis, necroptosis, and ferroptosis.

Methods

A comprehensive review of preclinical studies examining METH neurotoxicity mechanisms and melatonin's protective effects across all PCD pathways. This study summarized molecular targets, signaling cascades, and their translational potential.

Results

METH activates four distinct PCD pathways: (1) apoptosis via mitochondrial dysfunction and ER stress (increased CHOP, caspase-12 and cytochrome c release); (2) pyroptosis via NLRP3/NLRP1 inflammasome assembly (increased caspase-1 and IL-1β/IL-18); (3) necroptosis via RIPK1/RIPK3/MLKL signaling; and (4) ferroptosis via GPX4 downregulation, iron dysregulation, and lipid peroxidation. Melatonin simultaneously inhibits all pathways through antioxidant activity, mitochondrial protection, anti-inflammatory effects, and direct pathway targeting. Critically, we identified the concept of circadian-ferroptosis axis: METH disrupts circadian rhythms, enhancing ferroptosis through clockophagy (selective autophagy-mediated ARNTL/BMAL1 degradation). Melatonin provides dual protection through circadian restoration and direct ferroptosis inhibition. Studies demonstrate ARNTL-dependent anti-ferroptotic effects, as ARNTL knockdown abolishes melatonin's protection, revealing mechanistic integration between chronobiotic and neuroprotective actions.

Conclusions

Melatonin exhibits exceptional multi-target neuroprotection against METH toxicity. The circadian-ferroptosis-METH-melatonin nexus represents an emerging conceptual framework with implications for neurodegenerative diseases and substance use disorders. Clinical trials are urgently warranted given excellent safety profile and critical unmet need.

Subjects

MeSH terms (MEDLINE)

MelatoninMethamphetamineNeuroprotective AgentsApoptosisFerroptosisCircadian RhythmHumansAnimalsCentral Nervous System StimulantsSignal Transduction

Author keywords

Methamphetamine ; Melatonin ; Apoptosis ; Pyroptosis ; Necroptosis ; Ferroptosi…

Substances

MelatoninMethamphetamineNeuroprotective AgentsCentral Nervous System Stimulants

Authors and institutions

  • Chulabhorn International College of Medicine, Thammasat University (Rangsit Campus), Cooperative Learning Center, Piyachart 2, 99 Moo 18 Klong Luang, Rangsit, Pathumthani 12120, Thailand.
  • Department of Physiology, Faculty of Science, Mahidol University, 272 Rama VI Road, Ratchathewi District, Bangkok 10400, Thailand.
  • Princess Agrarajakumari Faculty of Nursing, Chulabhorn Royal Academy, 906 Thung Song Hong, Lak Si, Bangkok 10210, Thailand.
  • Research Center for Integrative Biomedical Science in Medicine and Health, Chulabhorn Royal Academy, Bangkok 10210, Thailand.

Funding

  • Chulabhorn Royal Academy (Fundamental Fund by National Science and Research Innovation Fund, NSRF)

Cite

APA

Pabalan, N., Lapmanee, S., Tharabenjasin, P., Suntornsaratoon, P., Thosingha, O., & Jenwitheesuk, A. (2026). A Comprehensive Review of Melatonin as Multi-Pathway Neuroprotectant Against Methamphetamine-Induced Programmed Cell Death: Discovery of the Circadian-Ferroptosis Axis. Neurosignals, 33(1), 1-18. https://doi.org/10.33594/000000861

Vancouver

Pabalan N, Lapmanee S, Tharabenjasin P, Suntornsaratoon P, Thosingha O, Jenwitheesuk A. A Comprehensive Review of Melatonin as Multi-Pathway Neuroprotectant Against Methamphetamine-Induced Programmed Cell Death: Discovery of the Circadian-Ferroptosis Axis. Neurosignals. 2026;33(1):1-18. doi:10.33594/000000861

BibTeX
@article{Pabalan2026,
  author = {Pabalan, Noel and Lapmanee, Sarawut and Tharabenjasin, Phuntila and Suntornsaratoon, Panan and Thosingha, Orapan and Jenwitheesuk, Anorut},
  title = {A Comprehensive Review of Melatonin as Multi-Pathway Neuroprotectant Against Methamphetamine-Induced Programmed Cell Death: Discovery of the Circadian-Ferroptosis Axis},
  journal = {Neurosignals},
  year = {2026},
  volume = {33},
  number = {1},
  pages = {1--18},
  doi = {10.33594/000000861}
}
Start for free →